Bixiye
QP44-17 New Pre-Authorization Form for Botulinum Toxin for Commercial Products
Taariikhda uu dhaqangalayo Barnaamijka: Des 05, 2017
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2931 - 2940 ee natiijooyinka 3167
Bixiye
P75-17 New Facility Reimbursement Policy for Incremental Nursing
Taariikhda uu dhaqangalayo Barnaamijka: Des 05, 2017
Bixiye
QP43-17 Hospital Providers FAQ for Restricted Recipient Program
Taariikhda uu dhaqangalayo Barnaamijka: Des 04, 2017
Bixiye
QP42-17 Professional Providers FAQ for Restricted Recipient Program
Taariikhda uu dhaqangalayo Barnaamijka: Des 04, 2017
Bixiye
QP41-17 Participation Status in the High Value and Access Networks
Taariikhda uu dhaqangalayo Barnaamijka: Nov 30, 2017
Bixiye
QP40-17 Provider Cost Data Update
Taariikhda uu dhaqangalayo Barnaamijka: Nov 30, 2017
Bixiye
P74-17 Payment Methodology Change for Interim Billing
Taariikhda uu dhaqangalayo Barnaamijka: Nov 29, 2017
Bixiye
P73-17 A New Drug, Hemlibra (emicizumab) Will Require Prior Authorization
Taariikhda uu dhaqangalayo Barnaamijka: Nov 28, 2017
Bixiye
QP39-17 Delay of Second Phase Transition with Magellan
Taariikhda uu dhaqangalayo Barnaamijka: Nov 21, 2017
Bixiye
QP38-17 Protocol for MHCP Subscribers that do not Provide Other Insurance Coverage Information
Taariikhda uu dhaqangalayo Barnaamijka: Nov 21, 2017